Image courtesy of Toshiba America Medical Systems
December 3, 2015 — Clinically viable model-based iterative reconstruction is now a reality with the launch of Toshiba America Medical Systems Inc.’s Forward projected model- based Iterative Reconstruction SoluTion (FIRST). FIRST, which is pending 510(k) clearance from the U.S. Food and Drug Administration (FDA), improves image quality with significant noise reduction while reducing radiation dose and drastically cuts the time needed for model-based computed tomography (CT) image reconstruction, helping providers make critical diagnoses and treatment decisions more effectively.
Available for the Aquilion One family of CT systems, FIRST improves high-contrast spatial resolution and helps to make exams safer for patients by providing reduction in dose, meaning customers don’t need to choose between safety and high-quality images.
Toshiba introduced FIRST at the 2015 Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 29 - Dec. 4.
For more information: www.medical.toshiba.com
March 25, 2026 
